Zobrazeno 1 - 10
of 24
pro vyhledávání: '"G J Cuchural"'
Autor:
Sherwood L. Gorbach, J. Rihs, Laura A. McDermott, Stacey Supran, Paul B. Iannini, Carl L. Pierson, G J Cuchural, S. Jenkins, Nilda V. Jacobus, David W. Hecht, David R. Snydman, Sydney M. Finegold, Lizzie J. Harrell
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Antimicrobial resistance, including plasmid-mediated resistance, among the species of the Bacteroides fragilis group is well documented. An analysis of the in vitro susceptibility of B. fragilis group species referred between 1995 and 1996 as well as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0f2ee7a92998a080509ce73c8c57b9
https://doi.org/10.1128/aac.43.10.2417
https://doi.org/10.1128/aac.43.10.2417
Publikováno v:
BMC Neurology
BMC Neurology, Vol 11, Iss 1, p 82 (2011)
BMC Neurology, Vol 11, Iss 1, p 82 (2011)
Background Previous studies suggest central nervous system involvement in chronic fatigue syndrome (CFS), yet there are no established diagnostic criteria. CFS may be difficult to differentiate from clinical depression. The study's objective was to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df7d0c5812485454d663c7340e098a6e
https://doi.org/10.1186/1471-2377-11-82
https://doi.org/10.1186/1471-2377-11-82
Publikováno v:
Scopus-Elsevier
There is limited information regarding the correlation of anaerobic susceptibility testing and outcome in the treatment of Bacteroides fragilis infections. We retrospectively analyzed the clinical outcomes of B. fragilis infections in patients treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c51acac84b56e9081a3c8aae337c83f
https://doi.org/10.1128/aac.36.3.540
https://doi.org/10.1128/aac.36.3.540
Autor:
Sydney M. Finegold, David R. Snydman, Timothy Cleary, J. P. O'Keefe, Gale B. Hill, Paul B. Iannini, Carl L. Pierson, N. A. Cornick, Nilda V. Jacobus, G J Cuchural
Publikováno v:
Journal of Antimicrobial Chemotherapy. 25:1011-1019
A nationwide survey to monitor the susceptibility of the Bacteroides fragilis group, which began in 1981, was continued during 1987. In addition to the eleven drugs evaluated in 1986, sulbactam, a potent beta-lactamase inhibitor, was tested alone and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f36828373323b258c36bb6a064b9423
https://doi.org/10.1093/jac/25.6.1011
https://doi.org/10.1093/jac/25.6.1011
Autor:
Victor L. Yu, J. Paul O'Keefe, Stephen G. Jenkins, John D. Rihs, David W. Hecht, Lizzie J. Harrell, Laura A. McDermott, Sherwood L. Gorbach, Paul B. Iannini, David R. Snydman, Carl L. Pierson, Sydney M. Finegold, G J Cuchural
Publikováno v:
Europe PubMed Central
Antimicrobial resistance, including plasmid-mediated resistance, among Bacteroides fragilis group species is well documented. A 5-year (1990-1994) prospective, eight-center survey of 3,177 clinical isolates of Bacteroides species was undertaken to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66fa7928a01d47399c7b023bb5c27ba5
https://pubmed.ncbi.nlm.nih.gov/8953108
https://pubmed.ncbi.nlm.nih.gov/8953108
Autor:
G J, Cuchural
Publikováno v:
Pharmacotherapy. 11(2 ( Pt 2))
A continuing nationwide susceptibility survey of the Bacteroides fragilis group, begun in 1981, is being conducted at the New England Medical Center. Review of susceptibility testing in years 1986 through 1988 is reported here. Totals of 557 strains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::85f72878aab415fc3fefbc9494db8818
https://pubmed.ncbi.nlm.nih.gov/2041832
https://pubmed.ncbi.nlm.nih.gov/2041832
Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group
Autor:
G J Cuchural, S M Finegold, F P Tally, C Pierson, J P O'Keefe, Gale B. Hill, T Cleary, Nilda V. Jacobus, P Iannini
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:479-480
A nationwide susceptibility survey of 557 isolates of the Bacteroides fragilis group was continued in 1986. The most active beta-lactam drugs were imipenem and ticarcillin-clavulanic acid, which had 0.2 and 1.7% resistance, respectively. The rank ord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5246cfe924b5eb8ac8f811dcdb29c271
https://doi.org/10.1128/aac.34.3.479
https://doi.org/10.1128/aac.34.3.479
Autor:
G J Cuchural, Francis P. Tally
Publikováno v:
Drug Intelligence & Clinical Pharmacy. 20:567-573
The Bacteroides fragilis group of organisms includes the most clinically important anaerobic bacteria. Optimal therapy of infections in which these organisms are involved includes adequate and timely surgical drainage of all collections, debridement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eb62eb528b1c424df7708934d1ade9a
https://doi.org/10.1177/106002808602000712
https://doi.org/10.1177/106002808602000712
Publikováno v:
Clinical Infectious Diseases. 6:S260-S269
The resistance of anaerobic bacteria to a number of antimicrobial agents has an impact on the selection of appropriate therapy for infections caused by these pathogens. Resistance to penicillin in Bacteroides fragilis has long been recognized. Most r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999f95a2acec77c9bb9d83f4a67d4d07
https://doi.org/10.1093/clinids/6.supplement_1.s260
https://doi.org/10.1093/clinids/6.supplement_1.s260
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 7:119-126
Resistance to cefoxitin among species of the Bacteroidesfragilis group of organisms has remained low (8%–10%) in a multicenter nationwide survey. However, a statistically significant increase in the percentage of B.fragilis group organisms resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9020ff1d36f29256943c80a48f0d9a7
https://doi.org/10.1016/0732-8893(87)90029-0
https://doi.org/10.1016/0732-8893(87)90029-0